Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,485.30 +97.68 0.63%
S&P 500 1,678.46 +9.30 0.56%
Nasdaq 3,516.75 +14.63 0.42%
Ticker Volume Price Price Delta
STOXX 50 2,830.98 +9.33 0.33%
FTSE 100 6,838.98 +35.11 0.52%
DAX 8,525.15 +52.95 0.62%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: Munich
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Adamis Pharmaceuticals Corp

+ Add to Watchlist

CY3A:GR

Company Profile for Adamis Pharmaceuticals Corp (CY3A)

Adamis Pharmaceuticals Corp. is a specialty pharmaceuticals company. The Company is focused on developing new treatment for viral infections, including influenza. Adamis markets and sells a line of prescription products for a variety of allergy, respiratory disease and pediatric conditions.

Contact Information

Adamis Pharmaceuticals Corp

2658 Del Mar Heights Rd
#555
Del Mar, CA 19512
United States
Phone: 1-858-401-3984

Key Executives for Adamis Pharmaceuticals Corp (CY3A)

Dennis J CarloPresident/CEODavid J MarguglioSenior VP:Corporate Dev
Robert O HopkinsVP:Finance/CFOKaren K DanielsVP:Operations
Thomas MollVP:Research

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil